Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 2, 2024Clinical and Experimental DermatologyOpen Access

Efficacy of omalizumab for the treatment of bullous pemphigoid: Spanish multicentre real-world experience

View Full Paper
Ask AI
Bookmark
Share

Authors

ÁVÁlvaro Aguado VázquezACAndrea Estebánez CorralesFRFrancisco Javier Melgosa Ramos

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Vázquez et al. (2024) studied this question.

synapsesocial.com/papers/68e76029b6db6435876d659fhttps://doi.org/10.1093/ced/llae067
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Omalizumab in the treatment of bullous pemphigoid: A single-center series of 15 cases2024 · 1 citations
  2. 2Omalizumab for the Treatment of Bullous Pemphigoid: A Single Center Experience2024
  3. 3Tissue Eosinophil Counts: A Promising Marker for Optimizing Omalizumab Treatment in Bullous Pemphigoid2025
  4. 4Emerging drugs for the treatment of bullous pemphigoid: what’s new on the horizon?2025
  5. 5An overview of bullous pemphigoid2024